Sources | Names Used |
---|---|
GDSC1000 | KIN001-260 |
PharmacoGx | KIN001-260 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | GYPA | GDSC1000 | pan-cancer | AAC | 0.15 | 6e-07 |
mRNA | GYPB | GDSC1000 | pan-cancer | AAC | 0.15 | 9e-07 |
mRNA | RHCE | GDSC1000 | pan-cancer | AAC | 0.15 | 1e-06 |
mRNA | RNASE6 | GDSC1000 | pan-cancer | AAC | 0.17 | 1e-06 |
mRNA | MYOC | GDSC1000 | pan-cancer | AAC | 0.14 | 2e-06 |
mRNA | IRAK3 | GDSC1000 | pan-cancer | AAC | 0.15 | 2e-06 |
mRNA | HDC | GDSC1000 | pan-cancer | AAC | 0.15 | 2e-06 |
mRNA | SNX20 | GDSC1000 | pan-cancer | AAC | 0.18 | 3e-06 |
mRNA | ZP2 | GDSC1000 | pan-cancer | AAC | 0.14 | 3e-06 |
mRNA | SCGB2B2 | GDSC1000 | pan-cancer | AAC | 0.14 | 4e-06 |